Browse Pet Safety Reports
23,590 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 23,590 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 23,590 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 5, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lethargy (see also Central nervous system depression in Neurological); Appeti... | Euthanized |
| May 4, 2024 | Cat | Domestic Mediumhair | Bexagliflozin | Weight loss; Product defect NOS | Ongoing |
| May 4, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Weight loss; Ketosis | Outcome Unknown |
| May 4, 2024 | Cat | Domestic Mediumhair | Velagliflozin Proline Monohydrate | Loose stool; Weight loss | Outcome Unknown |
| May 4, 2024 | Dog | Schnauzer - Giant | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm; Underdose; Weight gain; Weight loss | Outcome Unknown |
| May 4, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Diarrhoea; Weight loss | Outcome Unknown |
| May 4, 2024 | Cat | Domestic Longhair | Fluralaner/Moxidectin Spot-On | Application site hair loss; Application site hair change; Death; Lack of effi... | Died |
| May 4, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Weight loss; Ketosis; Diabetic ketoacidosis | Recovered/Normal |
| May 4, 2024 | Dog | Crossbred Canine/dog, Retri... | Fluralaner 13.64% 12-Week Chew | Emesis (multiple); Diarrhoea; Skin sore; Weight loss | Ongoing |
| May 4, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Foaming at the mouth; Vomiting; Weight loss; Hard stool; Ketosis; Not eating | Outcome Unknown |
| May 3, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Death by euthanasia; Weight loss; Urinary tract infection; Unable to stand; M... | Euthanized |
| May 3, 2024 | Dog | Retriever - Golden | Enrofloxacin; Silver Sulfadiazine | Rectal haemorrhage; Sneezing; Nasal bleeding; Eye haemorrhage; Thrombocytopen... | Ongoing |
| May 3, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Inappropriate urination; Hiding; Weight loss; Ketonuria; Death by euthanasia;... | Euthanized |
| May 3, 2024 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea; Weight loss; Glucosuria; Ketonuria | Ongoing |
| May 3, 2024 | Dog | Dog (unknown) | Bedinvetmab | Weight loss; Anorexia; Immune mediated haemolytic anaemia; Death | Died |
| May 3, 2024 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Weight loss; Haematuria; Anorexia | Outcome Unknown |
| May 2, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Weight loss; Ketonuria; Elevated globulins; Hyperkalaemia; Anaemia NOS; Lack ... | Outcome Unknown |
| May 2, 2024 | Cat | Domestic Shorthair | Frunevetmab | Lack of efficacy - NOS; Muscle atrophy (see also Muscle wasting); Unkempt hai... | Outcome Unknown |
| May 2, 2024 | Dog | Retriever - Golden, Dog (un... | Bedinvetmab | Weight loss; Decreased appetite | Ongoing |
| May 2, 2024 | Cat | Maine Coon, Cat (unknown) | Bexagliflozin | Diarrhoea; Weight loss | Recovered/Normal |
| May 2, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS; Abdominal pain; Weight loss; Muscle atrophy (see also... | Outcome Unknown |
| May 2, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Weight loss; Ketosis; Anorexia; Lethargy (see also Central nervous system dep... | Outcome Unknown |
| May 2, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Cough; Emesis (multiple); Diarrhoea; Not eating; Weight loss; Fever; Panting;... | Ongoing |
| May 2, 2024 | Cat | Domestic Longhair | Frunevetmab | Elevated symmetrical dimethylarginine (SDMA); Elevated blood urea nitrogen (B... | Ongoing |
| May 1, 2024 | Dog | Terrier (unspecified), Dog ... | Trilostane | Staring; Limb weakness; Weight loss; Hypocortisolaemia; Abnormal adrenocortic... | Outcome Unknown |
| May 1, 2024 | Cat | Domestic Mediumhair | Cyclosporine | Diarrhoea; Vomiting; Anorexia; Weight loss; Glucosuria; Isosthenuria; Elevate... | Outcome Unknown |
| May 1, 2024 | Dog | Akita | Bedinvetmab | Diarrhoea; Inappropriate defecation; Shaking; Behavioural disorder NOS; Ataxi... | Died |
| May 1, 2024 | Dog | Retriever - Labrador, Dog (... | Milbemycin Oxime; Praziquantel | Weight loss; Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| May 1, 2024 | Dog | Japanese Chin (Spaniel) | Pyrantel Pamoate;Sarolaner | Emesis (multiple); Cognitive disorder NOS; Circling - neurological disorder (... | Outcome Unknown |
| May 1, 2024 | Dog | Crossbred Canine/dog, Sheph... | Fluralaner 13.64% 12-Week Chew | Weight loss; Frequent urination; Increased appetite; Drinking a lot; Diabetes... | Recovered with Sequela |
| May 1, 2024 | Cat | Domestic Shorthair | Bexagliflozin | Hyperglycaemia; Eosinophilia; Monocytosis; Basophilia; Renal disorder NOS; St... | Ongoing |
| May 1, 2024 | Dog | Chihuahua | Trilostane | Weight loss; Inappetence; Fever; Abnormal ultrasound finding; Elevated renal ... | Outcome Unknown |
| May 1, 2024 | Dog | Dachshund - Miniature | Bedinvetmab | Chronic renal failure; Weight loss; Pica NOS; Polyuria; Polydipsia; Inappetence | Outcome Unknown |
| May 1, 2024 | Cat | Domestic Shorthair | Bexagliflozin | Weight loss; Hyperalbuminaemia; Hyperglycaemia; Blood in urine; Glucosuria; P... | Ongoing |
| May 1, 2024 | Dog | Rottweiler | Carprofen | Weight loss; Hind limb ataxia; Claw / hoof / nail disorder NOS; Muscle wasting | Ongoing |
| May 1, 2024 | Cat | Cat (other) | Selamectin;Sarolaner | Weight loss; General hair loss; Systemic disorder NOS | Outcome Unknown |
| May 1, 2024 | Dog | Dog (unknown) | Bedinvetmab | Wobbliness; Weight loss; Laboured breathing; Pacing; Vocalisation; Inappropri... | Outcome Unknown |
| May 1, 2024 | Dog | Samoyed | Bedinvetmab | Abscess NOS; Weight loss | Ongoing |
| May 1, 2024 | Cat | Domestic Shorthair | Bexagliflozin | Skin disorders NOS; Localised hair loss; Urinary tract disorder NOS; Elevated... | Outcome Unknown |
| May 1, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Partial anorexia; Elevated creatinine; Weight loss | Outcome Unknown |
| May 1, 2024 | Cat | Domestic Shorthair | Bexagliflozin | Excessive thirst; Weight loss; Ketosis; Hyperglycaemia; Other abnormal test r... | Recovered/Normal |
| May 1, 2024 | Dog | Maltese, Crossbred Canine/dog | Trilostane | Lack of efficacy - NOS; Decreased appetite; Weight loss; Elevated blood urea ... | Outcome Unknown |
| May 1, 2024 | Cat | Domestic Shorthair | Bexagliflozin | Ketosis; Decreased appetite; Anorexia; Weight loss | Outcome Unknown |
| May 1, 2024 | Dog | Dalmatian | Melarsomine Dihydrochloride | Weight loss; Lethargy (see also Central nervous system depression in Neurolog... | Ongoing |
| May 1, 2024 | Dog | Shiba Inu | Trilostane | Elevated serum alkaline phosphatase (ALP); Hypocortisolaemia; Weight loss; Mu... | Outcome Unknown |
| Apr 30, 2024 | Cat | Domestic Shorthair | Frunevetmab | Ataxia; Limb weakness; Otitis externa; Epiphora; Decreased appetite; Reluctan... | Ongoing |
| Apr 30, 2024 | Dog | Spaniel (unspecified) | Trilostane | Low sodium-potassium ratio (Na:K ratio); High blood pressure; Proteinuria; El... | Euthanized |
| Apr 30, 2024 | Dog | Dachshund (unspecified) | Pyrantel Pamoate;Sarolaner | Weight loss; Hyperglycaemia; Vomiting; Drinking a lot; Death by euthanasia | Euthanized |
| Apr 30, 2024 | Dog | Retriever - Labrador | Galliprant | Anorexia; Panting; Lethargy (see also Central nervous system depression in Ne... | Euthanized |
| Apr 30, 2024 | Horse | Thoroughbred | Pergolide Mesylate | Hives (see also Skin); Skin lesion NOS; Weight loss; Wound | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.